HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: A potential mechanism of G2/M cell cycle arrest

Virology

Volumn 305, Issue 2, 2003, Pages 371-377

  Chowdhury, Iqbal H ^a   Wang, Xiao Fan ^b   Landau, Nathaniel R ^c   Robb, Merlin L ^a   Polonis, Victoria R ^a   Birx, Deborah L ^d   Kim, Jerome H ^d  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Cdk; Cell cycle; G2 M phase; HIV 1, Vpr; p21; p53; Transcription

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; PROTEIN SUBUNIT; VPR PROTEIN;

ARTICLE; BONE MARROW CELL; CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONCENTRATION RESPONSE; GENE ACTIVATION; GENE DELETION; GENE FUNCTION; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA TRANSCRIPTION; T LYMPHOBLAST; VIRUS GENE; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037455533     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1777     Document Type: Article

References (45)

1. Ando T., Kawabe T., Ohara H., Ducommun B., Itoh M., Okamoto T. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage [In Process Citation]. J. Biol. Chem. 276:2001;42971-42977.
2. Balotta C., Lusso P., Crowley R., Gallo R. C., Franchini G. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 67:1993;4409-4414.
3. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J. P., Sedivy J. M., Kinzler K. W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
4. Chandar N., Billig B., McMaster J., Novak J. Inactivation of p53 gene in human and murine osteosarcoma cells. Br. J. Cancer. 65:1992;208-214.
5. Chowdhury I. H., Chao W., Potash M. J., Sova P., Gendelman H. E., Volsky D. J. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 70:1996;5336-5345.
6. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990a;3097-3099.
7. Cohen E. A., Terwilliger E. F., Jalinoos Y., Proulx J., Sodroski J. G., Haseltine W. A. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 3:1990b;11-18.
8. Connor R. I., Chen B. K., Choe S., Landau N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;935-944.
9. Datto M. B., Li Y., Panus J. F., Howe D. J., Xiong Y., Wang X. F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;5545-5549.
10. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N. R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
11. Dulic V., Stein G. H., Far D. F., Reed S. I. Nuclear accumulation of p21Cip1 at the onset of mitosis: A role at the G2/M-phase transition. Mol. Cell Biol. 18:1998;546-557.
12. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
13. Fauci A. S. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science. 239:1988;617-622.
14. Goh W. C., Rogel M. E., Kinsey C. M., Michael S. F., Fultz P. N., Nowak M. A., Hahn B. H., Emerman M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nature Med. 4:1998;65-71.
15. Grand R. J., Lecane P. S., Owen D., Grant M. L., Roberts S., Levine A. J., Gallimore P. H. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Virology. 210:1995;323-334.
16. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
17. Hattori N., Michaels F., Fargnoli K., Marcon L., Gallo R. C., Franchini G. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;8080-8084.
18. He J., Choe S., Walker R., Di Marzio P., Morgan D. O., Landau N. R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
19. Heinzinger N. K., Bukinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M. A., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
20. Hrimech M., Yao X. J., Branton P. E., Cohen E. A. Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO J. 19:2000;3956-3967.
21. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
22. Jowett J. B., Planelles V., Poon B., Shah N. P., Chen M. L., Chen I. S. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
23. Kessis T. D., Slebos R. J., Nelson W. G., Kastan M. B., Plunkett B. S., Han S. M., Lorincz A. T., Hedrick L., Cho K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA. 90:1993;3988-3992.
24. Komoto S., Kinomoto M., Horikoshi H., Shiraga M., Kurosu T., Mukai T., Auwanit W., Otake T., Oishi I., Ikuta K. Ability to induce p53 and caspase-mediated apoptosis in primary CD4+ T cells is variable among primary isolates of human immunodeficiency virus type 1 [In Process Citation]. AIDS Res. Hum. Retroviruses. 18:2002;435-446.
25. Kondo E., Gottlinger H. G. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J. Virol. 70:1996;159-164.
26. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 72:1993;541-550.
27. Lu Y. L., Bennett R. P., Wills J. W., Gorelick R., Ratner L. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69:1995;6873-6879.
28. Lu Y. L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:1993;6542-6550.
29. Mahalingam S., Khan S. A., Murali R., Jabbar M. A., Monken C. E., Collman R. G., Srinivasan A. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA. 92:1995;3794-3798.
30. Mahalingam S., MacDonald B., Ugen K. E., Ayyavoo V., Agadjanyan M. G., Williams W. V., Weiner D. B. In vitro and in vivo tumor growth suppression by HIV-1 Vpr. DNA Cell Biol. 16:1997;137-143.
31. Masuda M., Nagai Y., Oshima N., Tanaka K., Murakami H., Igarashi H., Okayama H. Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J. Virol. 74:2000;2636-2646.
32. McLinden R. J., Lewis B., Michael N. L., Redfield R. R., Birx D. L., Kim J. H. Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors. J. Hum. Virol. 1:1997;30-36.
33. Medema R. H., Klompmaker R., Smits V. A., Rijksen G. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene. 16:1998;431-441.
34. Morgan D. O. Principles of CDK regulation. Nature. 374:1995;131-134.
35. Nevins J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-429.
36. Paxton W., Connor R. I., Landau N. R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67:1993;7229-7237.
37. Re F., Braaten D., Franke E. K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
38. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
39. Stewart S. A., Poon B., Jowett J. B., Chen I. S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:1997;5579-5592.
40. Subbramanian R. A., Kessous-Elbaz A., Lodge R., Forget J., Yao X. J., Bergeron D., Cohen E. A. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187:1998;1103-1111.
41. Taylor W. R., Stark G. R. Regulation of the G2/M transition by p53. Oncogene. 20:2001;1803-1815.
42. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
43. Yamato K., Yamamoto M., Hirano Y., Tsuchida N. A human temperature-sensitive p53 mutant p53Val-138: Modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene. 11:1995;1-6.
44. Zhao Y., Cao J., O'Gorman M. R., Yu M., Yogev R. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J. Virol. 70:1996;5821-5826.
45. Zhou Y., Ratner L. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J. Virol. 74:2000;6520-6527.